Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,896,332
-
Share change
-
-863,990
-
Total reported value
-
$11,299,000
-
Price per share
-
$1.27
-
Number of holders
-
25
-
Value change
-
-$6,223,890
-
Number of buys
-
13
-
Number of sells
-
14
Institutional Holders of MARINUS PHARMACEUTICALS INC - COM (MRNS) as of Q2 2016
As of 30 Jun 2016,
MARINUS PHARMACEUTICALS INC - COM (MRNS) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,896,332 shares.
The largest 10 holders included
Canaan Partners VII LLC, FRANKLIN RESOURCES INC, SPHERA FUNDS MANAGEMENT LTD., ORBIMED ADVISORS LLC, Arrowpoint Asset Management, LLC, J. Goldman & Co LP, PUTNAM INVESTMENTS LLC, VANGUARD GROUP INC, DAFNA Capital Management LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.